EWM
BIIB icon

Elmwood Wealth Management’s Biogen BIIB Stock Holding History

Elmwood Wealth Management’s Portfolio BIIB Stock Details BIIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-15
Closed -$4K – 127
2021
Q4 		$4K Buy
+15
New +$3.86K ﹤0.01% 321
2021
Q2 		$5K Buy
+15
New +$4.54K ﹤0.01% 284
2020
Q3 		$0 Hold
1
– – ﹤0.01% 256
2020
Q2 		$0 Buy
+1
New +$301 ﹤0.01% 262

Other funds holding BIIB

Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Legal & General Group
Legal & General Group London, United Kingdom $480B AUM 42.84% 1-Year Est. Return

Elmwood Wealth Management's BIIB Position: Q1 2022 in Review

Elmwood Wealth Management sold out of Biogen (BIIB) in Q1 2022, closing a stake of 15 shares — an estimated $4K sold.

Elmwood Wealth Management first reported a position in BIIB in Q2 2020 and held it in 4 quarters. The position peaked at $5K in Q2 2021. 951 funds tracked by Wall St. Rank hold BIIB as of Q1 2022.

  • Elmwood Wealth Management reported no remaining Biogen position as of Q1 2022 after selling out during the quarter.
  • Elmwood Wealth Management sold 15 Biogen shares in Q1 2022, an estimated $4K.
  • Elmwood Wealth Management first reported a position in Biogen in Q2 2020 and held it in 4 quarters.
  • Elmwood Wealth Management's Biogen position peaked at $5K in Q2 2021.
  • 951 funds tracked by Wall St. Rank held Biogen as of Q1 2022.

Based on Elmwood Wealth Management's 13F filing for Q1 2022, filed 16 May 2022.